You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Omalizumab reduced inhaled corticosteroid use and exacerbations in childhood allergic asthma

https://doi.org/10.1136/ebm.7.1.12

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Sources of funding: Genentech, Inc. and Novartis Pharmaceuticals Corporation.

    • For correspondence: Dr H Milgrom, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA. milgromh{at}njc.org

    • ↵* See glossary.

    • ↵† Information provided by author.